Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
PONIF$0.12-0.00(-3.70%)Silver Pony Announces Closing of Up-Sized $1,600,015 Strategic Unit Offering[6:15:00 PM ET]ELME$0.07-1.70(-96.19%)Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026[5:47:00 PM ET]HHH$72.57+3.08(+4.43%)Howard Hughes Holdings Set to Join S&P SmallCap 600 Howard Hughes Holdings Inc. (NYSE: HHH) will replace Arcosa Inc. (NYSE: ACA) in the S&P SmallCap 600 effective prior to the opening of trading on...[5:45:00 PM ET]ALGRF$0.400.00(0.00%)Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita[5:30:00 PM ET]ZEFIF$0.45+0.02(+3.56%)Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million[5:29:00 PM ET]BLK$1,118.50-18.79(-1.65%)BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF[5:23:34 PM ET]ITFS$1.43-0.02(-1.10%)Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast[5:15:00 PM ET]FAGI$0.01-0.00(-13.33%)Full Alliance Group, Inc (OTC:FAGI) YAHBEE Highlights Community-Commerce Model for Agentic Commerce Era[5:15:00 PM ET]TGT$152.76-5.35(-3.38%)Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores[5:05:00 PM ET]NU$15.23+0.50(+3.39%)Notice to Market: Nu Holdings Ltd.[5:03:00 PM ET]POR$44.55-0.35(-0.78%)Portland General Electric Declares Dividend[5:00:00 PM ET]ANTX$3.55-0.09(-2.47%)AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)[5:00:00 PM ET]

BSX · NYSE

Boston Scientific Corporation

$45.85 -0.13 (-0.29%)

Company overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, as well as devices to treat various urological and pelvic conditions. It also provides implantable cardioverter and implantable cardiac resynchronization therapy defibrillators, pacemakers, and remote patient management systems.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Market cap
$66.4B
Employees
53,000
Headquarters
Marlborough, MA
Website
bostonscientific.com
CEO
Michael F. Mahoney
Listed
May 19, 1992
P/E
19.10
Dividend yield
0.00%

Company financials

Revenue
$20.6B
Gross profit
$14.5B
Operating income
$4.1B
EBITDA
$4.8B
Net income
$3.6B
EPS
$2.40
Total assets
$44.4B
Total debt
$11B
Gross margin
70.41%
Net margin
17.24%
Earnings yield
5.23%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

40.3747.2554.1361.0267.90
BSX 1D NYSE O44.72H46.05L44.62C46.01+1.50 (+3.37%)Vol16.40M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
BSX Stock news Insights Into Boston Scientific (BSX) Q3: Wall Street Projections for Key Metrics Zacks Investment Research
BSX Stock news Boston Scientific Corporation $BSX Stock Bought by Integrated Advisors Network LLC Defense World
BSX Stock news Boston Scientific: A Q3 Earnings Miss Likely Amid Product Recall, Cybersecurity Incident Seeking Alpha
BSX Legal BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties – BSX Business Wire
BSX Press release Belo Sun Receives Decision on Temporary Suspension of License Until Result of Settlement Hearing GlobeNewswire
BSX Stock news Banque Pictet & Cie SA Sells 694,882 Shares of Boston Scientific Corporation $BSX Defense World
BSX Stock news Boston Scientific (BSX) Rises Higher Than Market: Key Facts Zacks Investment Research
BSX Stock news Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know Zacks Investment Research
BSX Stock news Boston Scientific (NYSE:BSX) Reaches New 1-Year Low – Time to Sell? Defense World
BSX Press release Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer PRNewsWire
BSX Stock news Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know Zacks Investment Research
BSX Press release Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 GlobeNewsWire
BSX Stock news Boston Scientific's MedSurg Diversification Bolsters Growth Prospects Zacks Investment Research
BSX Stock news Boston Scientific Corporation (NYSE:BSX) Stock Has Average Price Target of $70.19 Defense World
BSX Stock news Boston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory Seeking Alpha
BSX Stock news Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? Zacks Investment Research
BSX Stock news Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase? Zacks Investment Research
BSX Stock news BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now? Zacks Investment Research
BSX Stock news Boston Scientific Corporation $BSX Shares Acquired by Corient Private Wealth LP Defense World
BSX Stock news Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade) Seeking Alpha
See more
FAQ

Questions about Boston Scientific Corporation

What does Boston Scientific Corporation do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, as well as devices to treat various urological and pelvic conditions. It also provides implantable cardioverter and implantable cardiac resynchronization therapy defibrillators, pacemakers, and remote patient management systems.
What is BSX's market cap?
Boston Scientific Corporation (BSX) is a listed stock with a live quote. The latest market cap on this page is $66.4B.
Where is Boston Scientific Corporation headquartered?
Boston Scientific Corporation is headquartered in Marlborough, MA.
How do I get BSX news from the API?
Call GET /v1/news?tickers=BSX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does BSX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for BSX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the BSX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs